Journal of Blood Disorders & Transfusion

4^th International Conference on Blood Malignancies & Treatment

April 18-19, 2016 Dubai, UAE

Posters & Accepted Abstracts

• Frondoside A potentiates the effects of conventional therapeutic agents in acute leukemia

  Fatma H Sajwani and Thomas E Adrian

  PDF HTML

• Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell lines

  Amani Mahbub, Le Maitre C L, Haywood-Small S L, Cross N A and Jordan-Mahy N

  PDF HTML

• Mucocutaneous relapse as unusual presentation of T-lineage acute lymphoblastic leukemia

  Mahdi Shahriari, Reza Fathpour and Fazl Saleh

  PDF HTML

• Umbilical cord derived mesenchymal stem cell enhanced the expression of myeloid lineage related antigens on differentiated hematopoietic stem cell

  Mohadese Hashem Boroojerdi

  PDF HTML

• Hypothesis: Fingolimod could lift the burden of lymphoma

  Arsalan Azimi

  PDF HTML

• Killer cell immunoglobulin-like receptor and HLA ligand pairs: A role in NK cell licensing in HLA class I mismatched hematopoietic stem cell transplantation for malignancy

  Jacek Nowak and Andrzej Lange

  PDF HTML

• European vs. 2015-World Health Organization clinical molecular and pathological classification of myeloproliferative neoplasms

  J J Michiels

  PDF HTML

• Genetic and epigenetic pathways in myelodysplastic syndromes

  Suresh C Jhanwar

  PDF HTML

• Lymphoma updates-What is new in 2016?

  Victor Yazbeck

  PDF HTML

• Chimeric antigen receptorâ??modified T cells for acute lymphoid leukemia

  Stephan A Grupp

  PDF HTML

• Stopping TKI in pediatric chronic myeloid leukemia: Are we there?

  Vijay Gandhi Linga

  PDF HTML

• Whole exome sequencing reveals the landscape of clonal evolution from MDS/MPD to sAML progression

  Hyeoung-Joon Kim

  PDF HTML

• Myelodysplastic syndrome: MDS

  Ahmad Ali Basha

  PDF HTML

• Staging malignant lymphoma using 3 Tesla whole-body diffusion-weighted magnetic resonance imaging

  Katja De Paepe

  PDF HTML

• The MPNs as a human inflammation model for cancer development

  Hans Hasselbalch

  PDF HTML

• The molecular rationale for steroid based therapy of leukemia: Diagnostic and therapeutic implications

  Eitan Yefenof

  PDF HTML

• Oncologic emergencies in children

  Ahmad Abdellatif Saleh Abu Mallouh

  PDF HTML

• Management of acute myeloid leukaemia in elderly and resource constrained setting

  Vijay Ramanan

  PDF HTML

• Role of protease-activated receptors (PARs) and G-proteins in thrombin induced monocyte/macrophage migration

  Ravisekhar Gadepalli

  PDF HTML

• Comprehensive approach vs. NGS

  Jianxiang (Jason) Chi

  PDF HTML

• Minimal residual disease: Evolution of technology and clinical impact

  Azza M Kamel

  PDF HTML

• Adult acute lymphoblastic leukemia biology: A gate towards cure

  Ahmed M L Bedewy

  PDF HTML

• Modification of haematological parameters in radiation and benzene exposure laborers as risk issue for blood cancer

  Fathelrahman Mahdi Hassan

  PDF HTML

• The role of morphology in molecular era: Where are we?

  Azly Sumanty

  PDF HTML

• Challenges associated with the effective management of hematological malignancies in developing countries

  Osaro Erhabor

  PDF HTML

• Hematopoietic stem cell transplantation

  Amandeep Kaur

  PDF HTML

• FLT3 mutations and their effect on overall survival

  Sadaf Shahab, Khaleeq un Nisa, Muhammad Nadeem, Danish Zahid, Saqib Ansari, Tasneem Farzana, Mehwesh Taj, Munira Borhany, Nuzhat Ahmed and Tahir S Shamsi

  PDF HTML

• Serum leptin and adiponectin levels in de novo acute myeloid leukemia patients: Correlation with clinical characteristics

  Nahla Ahmad Bahgat Abdulateef, Mahmoud M Kamel, Omima Salaheldin and Mohamed Ghareeb

  PDF HTML

• Evaluation of UK- ALL-X I treatment method in children with acute lymphoblastic leukemia in Bahrami Hospital in 2007-2014

  Ehsan Shahverdi

  PDF HTML